Bicycle Market to Exhibit Impressive Growth During the Forecast Period: Grand View Research Inc.

 

Bicycle Market Growth & Trends

The global bicycle market size is anticipated to reach USD 92.49 billion by 2028, registering a CAGR of 7.0% over the forecast period, according to a new report by Grand View Research, Inc. Increasing adoption of cycling as a form of leisure and awareness regarding the health benefits associated with cycling are the factors expected to bolster market growth. Bicycles are being preferred for short-distance commutes as they save considerable time as compared to other vehicles. Moreover, limited parking spaces and growing traffic congestions are prompting people to reconsider bicycles as a primary option for the commute.

Rising emphasis on the use of non-polluting vehicles for short-distance commutes by governments across the world is anticipated to positively influence market growth. The fact that bicycles do not emit any pollutants is projected to drive their demand in near future. Moreover, consumers are rapidly moving toward online distribution channels to buy a bicycle due to several key factors, including doorstep delivery and replacement and availability of a variety of products. Also, due to the outbreak of the COVID-19 pandemic, consumers are mainly focused on avoiding crowded places to prevent themselves from virus infections.

The road bicycle is expected to emerge as the fastest-growing segment over the forecast period. These happen to be the most basic bicycles that consumers prefer owing to their ease of use. These cycles do not require any sophisticated equipment required by mountain and hybrid bicycles. This factor is anticipated to bode well for the growth in demand over the forecast period. Moreover, dockless bicycle-sharing systems are expected to gain attention in the coming years as they enable users to locate and electronically unlock a nearby bicycle for rent. Produced originally in Europe, these systems are gaining acceptance, especially in Asian countries, including India and China.

Request a free sample copy or view report summary: Bicycle Market Report

Bicycle Market Report Highlights

• The global market is growing significantly as bike-sharing companies, particularly in Europe and Asia, are investing aggressively in expanding their operations
• The mountain bicycle segment is anticipated to expand at a CAGR exceeding 7% over the forecast period. Rising popularity in line with the increasing media coverage for mountain bicycle racing events and the establishment of new mountain biking circuits are expected to drive the growth
• Apart from being easy to use, electric bicycles can potentially shorten the journey time. Moreover, advances in battery technology have resulted in the advent of lighter rechargeable batteries that can support longer journeys. These factors are attributed to the growth of the electric bicycle segment
• The men segment is expected to expand significantly at a CAGR of over 7.2% over the forecast period as men would continue to outnumber women and kids in terms of opting for a bicycle commute. The number of men opting for bicycle commutation was higher than that of women and kids in 2019
• Asia Pacific was the dominant regional market in 2020 with a revenue share exceeding 34%. Governments in Asian nations, particularly Japan, China, and Singapore, among others, are investing aggressively in establishing the infrastructure necessary to encourage and support bicycle commutation
• Leading market incumbents are Accell Group; Dorel Industries Inc.; Giant Bicycles; Merida Industry Co., Ltd.; and Trek Bicycle Corporation. They dominated the market in 2020 leveraging a continuous emphasis on expanding their market share through mergers and acquisitions

Access Press Release of Bicycle Market@ https://www.grandviewresearch.com/press-release/global-bicycle-market

Bicycle Market Segmentation

Grand View Research has segmented the global bicycle market based on product, technology, end user, distribution channel, and region:

Bicycle Product Outlook (Revenue, USD Million, 2016 - 2028)

• Mountain Bicycle
• Hybrid Bicycle
• Road Bicycle
• Others

Bicycle Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Electric
• Conventional

Bicycle End-user Outlook (Revenue, USD Million, 2016 - 2028)

• Men
• Women
• Kids

Bicycle Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Online
• Offline

Bicycle Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa

List of Key Players of Bicycle Market

• Accell Group
• Atlas Cycles (Haryana) Ltd.
• Avon Cycles Ltd.
• Cervelo
• Dorel Industries Inc.
• Giant Bicycles
• Merida Industry Co., Ltd
• Specialized Bicycle Components, Inc.
• SCOTT Sports SA
• Trek Bicycle Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Leisure Boat Market Detail Outlook & Analysis During 2021-2028

 

Leisure Boat Market Growth & Trends

The global leisure boat market size is expected to reach USD 57.92 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.5% from 2021 to 2028. The increasing popularity of marine and coastal tourism, coupled with the growing inclination toward yachting as a recreational activity, is a primary factor driving the market. Although the ongoing Covid-19 pandemic has proved to be a major hindrance for the market, the gradual re-opening of the economies and eased restrictions are paving the way to bring the market back on track. Besides, the growing urge among masses to involve in leisure activities in the post-lockdown period further presents bright opportunities for the market over the forecast period.

The tourism industry has changed drastically over the last few years with the increasing popularity of marine and coastal tourism activities. The world economy is witnessing healthy growth and markets, such as the U.S., are witnessing growth in the per-capita income of the individuals, which, in turn, has resulted in a rise in the disposable income of consumers. A rise in the number of High-Net-Worth Individuals (HNWIs) is expected to drive consumers to spend more on leisure activities, thus boosting demand for recreational boats.

The increasing number of boat shows and water sporting events are attracting a large number of boaters worldwide. The leading manufacturers are sponsoring boat shows and events, which, in turn, is enhancing the popularity of leisure boats. North America is poised to remain the most prominent region in terms of revenue generation during the forecast period. The rising demand for recreational watercraft is driven by factors such as improving economic conditions and the rising disposable income of consumers in the region. The U.S. is anticipated to witness significant growth over the forecast period. Demand in the country is majorly driven by factors such as the increasing number of high-net-worth individuals and the growing popularity of water sports and fishing activities.

Furthermore, there are changes taking place in boat building, such as the adoption of IoT technology that enables appliances, physical structures, vehicles, smartphones, wearable devices, and heavy equipment to be connected, while facilitating an exchange of information through a single network. The connected boat provides enhanced safety, security, and accuracy, while also improving the efficiency of the boat by digitalizing and optimizing various functions.

Measures taken by various governments to promote tourism activities in their countries are also boosting the market growth. Countries with rich natural resources, such as vast coastlines and large inland water bodies, are undertaking initiatives to promote recreational boating activities to increase their tourism business. Countries such as the U.S. have a vast coastline, a highly developed infrastructure, and a large population that participates in leisure boating activities, thus opening new growth opportunities for the market. Additionally, the French government is encouraging yacht manufacturers by providing them support in various forms, thus enabling them to invest in expanding their yacht maintenance and construction capacities.

Request a free sample copy or view report summary: Leisure Boat Market Report

Leisure Boat Market Report Highlights    

• Leisure boats are projected to witness a strong growth in demand owing to the initiatives taken by the governments worldwide for the development of coastal and marine tourism and the rising disposable income of citizens in emerging economies
• Sports yachts are expected to witness greater demand in developed countries owing to the active participation of people in marine sporting events as well as recreational boating activities
• Boat manufacturers are increasingly organizing boat shows worldwide to attract a greater number of potential buyers, and thereby expand their customer base
• By type, the used leisure boat segment held the largest revenue share of over 76.0% in 2020 owing to the prompt and easy availability and relatively lower cost
• North America held the largest revenue share of more than 45.5% in 2020 owing to the greater demand for recreational activities across the region, especially in the U.S.
• Key players in the market include Avon Marine; Azimut Benetti Group; Baja Marine; Bavaria Yachtbau GmbH; Bombardier Recreational Products (BRP) Inc.; Brunswick Corporation; Ferretti S.P.A.; and Fountain Powerboats, Inc.

Access Press Release@ https://www.grandviewresearch.com/press-release/leisure-boat-market

Leisure Boat Market Segmentation

Grand View Research has segmented the global leisure boat market based on type and region:

Leisure Boat Type Outlook (Revenue, USD Billion, 2016 - 2028)

• New Leisure Boat
  • Motorized/Power Boats
    • Personal Watercraft
    • Outboard Boats
    • Yachts
      • Yacht Type
        • Super Yachts
        • Flybridge Yachts
        • Sport Yachts
        • Long Range Yachts
        • Others
      • Yacht Length
        • Up to 20 ft.
        • 20-50 ft
        • Above 50 ft.
      • Other 
    • Non-motorized Boats
      • Kayaks
      • Canoes
      • Others
    • Used Leisure Boat
      • Motorized/Power Boats
        • Personal Watercraft
        • Outboard Boats
        • Yachts
          • Yacht Type
            • Super Yachts
            • Flybridge Yachts
            • Sport Yachts
            • Long Range Yachts
            • Others
          • Yacht Length
            • Up to 20 ft.
            • 20-50 ft
            • Above 50 ft.
          • Other 
        • Non-motorized Boats
          • Kayaks
          • Canoes
          • Others
        • Monitoring Equipment
          • Boat and Yacht Monitoring Solutions
          • IoT Sensors
            • Water Detection Sensors
            • Voltage Meters
            • Temperature And Motion Sensors
            • Others
          • Telematics Solutions
          • Others

Leisure Boat Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Mexico
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Sweden
  • Spain
• Asia Pacific
  • India
  • China
  • Japan
  • Singapore
  • South Korea
• South America
  • Brazil
• Middle East & Africa (MEA)

List of Key Players in the Leisure Boat Market

• Avon Marine
• Azimut Benetti Group
• Baja Marine
• Bavaria Yachtbau GmbH
• Bombardier Recreational Products (BRP) Inc.
• Brunswick Corporation
• Chaparral Boats, Inc.
• Farr Yacht Design, Ltd.
• Ferretti S.P.A.
• Fountain Powerboats, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Monopolar Electrosurgery Instrument Market Expectations Acme Prominent Development in Developed Regions, Details Gvr Study

 Monopolar Electrosurgery Instrument Market Growth & Trends

The global monopolar electrosurgery instrument market size is expected to reach USD 3.0 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.2% from 2021 to 2027. monopolar electrosurgery instrument are majorly used in gynecology and urology procedures to precisely cut and extract tissues. The devices are most commonly used in Laparoscopic Ovarian Drilling (LOD) procedures to manage Polycystic Ovary Syndrome (PCOS). According to the Centers for Disease Control and Prevention (CDC), PCOS is among the major cause of female infertility, affecting 6 - 12% or 5 million U.S. women between the 18-45 age group.

Frequent product launch, increasing prevalence of chronic conditions, and growing preference for minimally invasive procedures have augmented the demand for monopolar electrosurgery devices. For instance, in September 2019, Ethicon, a Johnson and Johnson subsidiary launched a MEGADYNE MEGA SOFT universal plus reusable patient return electrode. The dispersal electrode eliminates adhesive-related injuries and is eco-friendly.

The market is highly fragmented with presence of large number of local manufacturers in developing regions. These companies offer technologically advanced products at competitive prices. Local manufacturing helps in keeping the final product prices minimum. Major market players are focusing to set manufacturing units in Asian countries such as China and India.

Request a free sample copy or view report summary: Monopolar Electrosurgery Instrument Market Report

Monopolar Electrosurgery Instrument Market Report Highlights

• North America accounted for the largest revenue share in 2020 owing to the factors such aspresence of key players, increasing prevalence of chronic diseases, and the presence of trained professionals
• By type, the generators segment is expected to register the highest CAGR during the forecast period owing to the high surgical efficacy offered by the device
• By application, the cardiovascular segment is expected to register the highest CAGR during the forecast period owing to the increasing prevalence of the condition due to changing lifestyle and geriatric population
• By end use, the hospital segment accounted for the largest market share owing to the increasing adoption of advanced devicesand growing preference for minimally invasive procedures

Access Press Release@ https://www.grandviewresearch.com/press-release/global-monopolar-electrosurgery-instrument-market

Monopolar Electrosurgery Instrument Market Segmentation

Grand View Research has segmented the global monopolar electrosurgery instrument market based on type, application, end use, and region.

Monopolar Electrosurgery Instrument Type Outlook (Revenue, USD Million, 2016 - 2027)

• Hand Instrument
• Generator
• Dispersive electrodes
• Accessories

Monopolar Electrosurgery Instrument Application Outlook (Revenue, USD Million, 2016 - 2027)

• General surgery
• Neurosurgery
• Cardiovascular surgery
• Others

Monopolar Electrosurgery Instrument End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals
• Specialty clinics
• Ambulatory Surgical centers

Monopolar Electrosurgery Instrument Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Monopolar Electrosurgery Instrument Market

• Conmed
• Olympus Corporation
• Medtronic Plc
• KLS Martin
• Braun Melsungen AG
• Stryker
• Apyx Medical Corporation
• Johnson & Johnson
• Integra LifeSciences
• Stingray Surgical Products, LLC
• Surgical Holdings

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Radiation Oncology Market is Anticipated to Rise at a CAGR of 7.0% by 2028: Grand View Research Inc.

 

Radiation Oncology Market Growth & Trends

The global radiation oncology market size is expected to reach USD 11.7 billion by 2028, registering a CAGR of 7.0% over the forecast period, according to a new report by Grand View Research, Inc. The rising incidence of cancer and technological advancement in radiation therapy equipment are some of the major factors driving the growth of the market.

There have been various technological advancements in radiotherapy equipment over the last decade, which has been a major factor for growth. Advancement from 2D to 3D conformal radiotherapy, motion tracking, and real-time imaging has helped improve radiation targeting and thereby reduce exposure to the surrounding healthy tissues. For instance, Accuray Incorporated introduced its motion monitoring and correction tools, Synchrony, for the Radixact device in April 2019. In contrast to traditional radiotherapy devices, this technology increases dosage accuracy and treatment times and is comparatively more effective.

Strategies such as partnerships, innovative product launches, and acquisitions are the priority of major players in the industry. For instance, in February 2020, Varian received FDA 510K clearance for its Ethos Therapy. It is an AI-driven solution designed to deliver an entire adaptive treatment plan in 15 minutes, including patient set-up to treatment delivery. In December 2019, Elekta signed a non-binding MoU with ViewRay, Inc. for the advancement of the knowledge and application of MR-LINACs.

According to an article published in Seminars in Radiation Oncology in 2017, it is expected that in low- and middle-income countries alone, more than 12,000 additional treatment machines will be needed by 2035. Besides, by 2035, it is projected that China, India, and Brazil will need over 3,800, 1,200, and 400 additional equipment, respectively. Companies are taking several initiatives to meet this demand. For instance, in 2019, Tata Trust signed a 3-year agreement with Varian Medical Systems Inc. for the installation of new advanced radiotherapy equipment in India, to improve patient access to treatment.

However, the lack of skilled radiotherapy professionals is expected to be a major restraining factor for the growth of the market, particularly in developing countries. The recommended number of radiation oncologists in the developed world is around 4 per million population. There are around 0.8 radiation oncologists per million population in India. Similar is the situation in other countries in the Indian sub-continent.

Request a free sample copy or view report summary: Radiation Oncology Market Report

Radiation Oncology Market Report Highlights

• Due to the high availability of External Beam Radiation Therapy (EBRT) equipment and penetration of innovative diagnostic instruments and understanding of available treatment options, EBRT dominated the market in 2020
• In IBRT application, the prostate cancer segment dominated the market in 2020, majorly due to the promising applications for brachytherapyin the treatment of prostate cancer
• In 2020, North America dominated the market and accounted for a revenue share of more than 44.0%. Favorable reimbursement policies, quality of healthcare infrastructure, and the presence of key players in the region are some of the factors driving the market in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-radiation-oncology-market

Radiation Oncology Market Segmentation

Grand View Research has segmented the global radiation oncology market on the basis of type, technology, application, and region:

Radiation Oncology Type Outlook (Revenue, USD Million, 2017 - 2028)

• EBRT
  • Linear Accelerators (Linacs)
  • Compact Advanced Radiotherapy Systems
    • Cyberknife
    • Gamma Knife
    • Tomotherapy
  • Proton Therapy
    • Cyclotron
    • Synchrotron
  • Internal Beam Radiation Therapy
    • Brachytherapy
      • Seeds
      • Applicators and Afterloaders
      • Electronic Brachytherapy
    • Systemic Beam Radiation Therapy
    • Others

 Radiation Oncology Technology Outlook (Revenue, USD Million, 2017 - 2028)

• EBRT 
  • Image-Guided Radiotherapy (IGRT)
  • Intensity Modulated Radiotherapy (IMRT)
  • Stereotactic Technology
  • Proton Beam Therapy
  • 3D Conformal Radiotherapy (3D CRT)
  • Volumetric Modulated Arc Therapy (VMAT)
• Brachytherapy
  • Low-Dose Rate Brachytherapy
  • High-Dose Rate Brachytherapy

Radiation Oncology Application Outlook (Revenue, USD Million, 2017 - 2028)

• EBRT
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Colorectal Cancer
  • Others
• Internal Beam Radiation Therapy
  • Prostate Cancer
  • Gynecological Cancer
  • Breast Cancer
  • Cervical Cancer
  • Penile Cancer
  • Others

Radiation Oncology Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • Italy
  • Russia
  • France
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
• Latin America
  • Mexico
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Radiation Oncology Market

• Varian Medical Systems, Inc.
• Elekta AB
• Accuray Incorporated
• Ion Beam Applications (IBA)
• R. BARD, INC. (BD)
• Isoray Medical
• Mevion Medical Systems, Inc.
• Nordion Inc.
• NTP Radioisotopes SOC Ltd.
• Curium Pharma
• Viewray Technologies, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Demand Blood Glucose Monitoring Devices Market Increasing in Most Part of World 2028

 Blood Glucose Monitoring Devices Market Growth & Trends

The global blood glucose monitoring devices market size is expected to reach 19.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.6% from 2021 to 2028. The market growth is propelled by the rising diabetes prevalence worldwide and increasing geriatric population. Moreover, rising awareness about diabetes preventive care and new product launches are expected to boost market growth.

Blood glucose monitoring (BGM) devices are used to measure blood glucose levels in diabetes patients. These devices help in analyzing glucose level pattern as it provides continuous and real-time blood sugar reading. It also helps patients to decide the amount of food intake and dosage of insulin. Furthermore, factors such as sedentary lifestyle, consumption of junk food and alcohol, smoking, and surge in the need for safer and faster diagnosis are propelling the market growth.

Obesity is also one of the major factors in propelling the prevalence of diabetes. According to the WHO, over 650 million people were obese in 2016 and this number is expected to grow further during the forecast period. Additionally, the market is expected to witness a high growth rate during the forecast period due to the continuous efforts for diabetes control by government and healthcare organizations, such as the International Diabetes Federation (IDF). Such organizations provide the required expertise and support diabetes awareness campaigns through a network of stakeholders and partners. Moreover, increasing health care funding is anticipated to propel the market growth.

Request a free sample copy or view report summary: Blood Glucose Monitoring Devices Market Report

Blood Glucose Monitoring Devices Market Report Highlights

• North America held the largest market share in 2020 owing to favorable reimbursement policies, local presence of key players, and supportive government initiatives
• Based on product, the self-monitoring devices segment held the largest market share in 2020 and is expected to grow at a significant pace over the forecast period. The testing strips segment of self-monitoring devices held the largest share of more than 40.0% in 2020 and is projected to grow at a healthy CAGR over the forecast period
• The continuous blood glucose monitoring devices segment is expected to be the fastest-growing segment during the forecast period
• By end-use, the home care segment is expected to grow at a rapid pace during the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-blood-glucose-monitoring-devices-market

Blood Glucose Monitoring Devices Market Segmentation

Grand View Research has segmented the global blood glucose monitoring devices market on the basis of product, end-use, and region:

Blood Glucose Monitoring Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Self-monitoring Devices
  • Blood Glucose Meter
  • Testing Strips
  • Lancets
• Continuous Blood Glucose Monitoring Devices
  • Sensors
  • Transmitter & Receiver
  • Insulin Pumps

Blood Glucose Monitoring Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Home Care
• Diagnostic Centers

Blood Glucose Monitoring Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Poland
  • Russia
  • Ukraine
  • Belarus
  • Turkey
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Kazakhstan
  • Uzbekistan
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Blood Glucose Monitoring Devices Market

• Abbott Laboratories
• Medtronic plc
• Hoffmann-La Roche Ltd.
• Bayer AG
• Lifescan, Inc.
• Dexcom, Inc.
• Sanofi
• Elly Lilly and Company
• B Braun Melsungen AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Primary Cell Culture Market To Hold a High Potential for Growth by 2028| Key participants Thermo Fisher, GE Healthineers

 

Primary Cell Culture Market Growth & Trends

The global primary cell culture market size is expected to reach USD 8.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2021 to 2028. The market growth is owing to several factors such as advancement in genetic engineering, rising demand for regenerative medicines, and robust funding for cellular therapies development.

In addition, the growing focus on functional biology can be further attributed to the market growth. Several R&D investments for the development of novel solutions have increased the demand for culture medium. For instance, in April 2020, Sumitomo Chemical invested USD 30 million in Conagen a U.S.-based company. The investment was aimed at strengthening its alliance and developing high functional products as well as processes using synthetic biology.

Moreover, the ongoing COVID-19 pandemic has provided an opportunity for researchers to study and understand the new variants of the virus with the application of primary cell culture. The large pool of human cells from various genetic backgrounds and varied health conditions facilitated researchers to conduct experiments for thorough results. Various institutions have shown their support and interest in scientific research to match specialized cell culture media.

Request a free sample copy or view report summary: Primary Cell Culture Market Report

Primary Cell Culture Market Report Highlights

• The reagents and supplements segment accounted for the largest revenue share in 2020 owing to their growing application for maintaining primary cell viability
• The primary cells segment is expected to witness the fastest growth rate over the forecast period owing to the increasing research initiatives for cancer and rare diseases
• The enzymatic degradation segment held the largest revenue share in 2020 due to the advantage of obtaining a high cellular yield through enzymatic disaggregation
• The mechanical separation segment is expected to witness lucrative growth over the forecast period owing to its large adoption as it’s an inexpensive, quick, and easy method for disaggregation of cellular entities
• The animal cells segment accounted for the largest revenue share in 2020 owing to rising applications for vaccine development
• The human cells segment is expected to witness substantial growth over the forecast period as they are extensively used for preclinical and clinical analyses in cancer research
• The vaccine production segment dominated the market in 2020 owing to the rising focus on the development of new vaccines targeting new infections such as COVID-19
• The stem cell therapy segment is expected to witness the fastest CAGR over the forecast period owing to the growing number of studies for designing therapies for genetic disorders
• North America held the largest revenue share in 2020. The growth of the market in this region is owing to intensive research for the development of new therapies
• Companies operating in the market are launching new products for primary cell cultures. For instance, in January 2021, Lonza launched customizable and high-quality cryopreserved Leukopaks. It is a product derived from enriched leukapheresis, which contains high concentrations of peripheral blood mononuclear such as B and T cells, and monocytes

Access Press Release@ https://www.grandviewresearch.com/press-release/global-primary-cell-culture-market

Primary Cell Culture Market Segmentation

Grand View Research has segmented the global primary cell culture market based on product, separation methods, cell type, application, and region:

Primary Cell Culture Product Outlook (Revenue, USD Million, 2017 - 2028)

• Primary Cells
  • Fat
  • Blood
  • Nerve
  • Bone
  • Endothelial
  • Skin
  • Muscle
  • Stem
  • Others
• Reagents and Supplements
  • Attachment Solutions
  • Buffers and Salts
  • Freezing Media
  • Sera
  • Growth Factors and Cytokines
  • Other
• Media
  • Fat Cells Media
  • Blood Cells Media
  • Nerve Cells Media
  • Bone Cells Media
  • Endothelial Cells Media
  • Skin Cells Media
  • Muscle Cells Media
  • Stem Cells Media
  • Others

Primary Cell Culture Separation Methods Outlook (Revenue, USD Million, 2017 - 2028)

• Explant Method
• Enzymatic Degradation
  • Trypsin
  • Collagenase
  • Protease
  • Pronase
  • Dispase
  • Hyaluronidase
  • Neuraminidase
  • Elastase
  • DNase
  • Papain
  • Accutase
  • Others
• Mechanical Separation
• Others

Primary Cell Culture Cell Type Outlook (Revenue, USD Million, 2017 - 2028)

• Animal
• Human

Primary Cell Culture Application Outlook (Revenue, USD Million, 2017 - 2028)

• Tissue Culture & Tissue Engineering
• Vaccine Production
• Gene Therapy and Regenerative Medicine
• Toxicity Testing and Drug Screening
• Cancer Research
• Model System
• Virology
• Prenatal Diagnosis
• Stem Cell Therapy
• Others

Primary Cell Culture Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Primary Cell Culture Market

• Thermo Fisher Scientific, Inc.
• Lonza
• Merck
• Corning Incorporated
• Danaher  
• PromoCell GmbH
• ATCC
• FUJIFILM Irvine Scientific, Inc.
• Mattek
• Axol Bioscience Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Downstream Processing Market Expected to Witness a Sustainable Growth over 2028

 Downstream Processing Market Growth & Trends

The global downstream processing market size is expected to reach USD 69.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.9% from 2021 to 2028. The capacity requirements during the development of biologic drugs have changed over the past few years, wherein the demand for manufacturing high-volume products has shifted to developing small-volume, high potency products. This creates new avenues for single-use technologies.

As adoption of small-scale, single-use systems for process development and downstream processing is already high, evolutionary changes are expected in the area of single-use technologies for manufacturing small-volume, highly potent drugs. The development of novel film chemistries, closed systems, automation in clinical-scale single-use systems, and smart sensors are some noteworthy advancements in the field.

A rise in applications of downstream processing for the manufacture of biopharmaceuticals is expected to bring growth opportunities to the market. This has also led to an increase in strategic deals and development in the market. For instance, in February 2021, Evozyne, LLC collaborated with a leading rare disorders drug manufacturer for the manufacture and marketing of novel biopharmaceuticals for immune modulation.

Request a free sample copy or view report summary: Downstream Processing Market Report

Downstream Processing Market Report Highlights

• Chromatography systems accounted for the largest revenue share of products owing to the high adoption of chromatography for biopharmaceutical purification
• The advent of single-use chromatography systems that bring an 80.0% reduction of the use of water and chemicals for buffer has further increased the adoption of chromatography for downstream processing of bio-therapeutics
• Filters are anticipated to grow at a lucrative rate. Efforts taken by key players to develop intelligent membranes for purification and separation fuels this growth 
• Purification by chromatography accounted for the largest share of the global market, as it can be employed across all steps of a downstream process. The technique is also crucial in bioprocessing to obtain pure biologics  
• Solid-liquid separation is anticipated to grow at the fastest rate owing to the use of filtration and chromatography techniques for efficient separation 
• Antibiotic production dominated the revenue generation in 2020 owing to the wide use of antibiotics for the treatment of a variety of clinical disorders including infectious diseases and cancer
• A rise in occurrences of antibiotic resistance also propels the industrial-scale development of novel antibiotic candidates
• North America dominated the regional segment in 2020 owing to the local presence of large in-house biopharmaceutical manufacturing facilities
• Asia Pacific registered the fastest growth rate owing to rise in contract development services in emerging Asian economies
• Key players are investing in the bioprocessing of vaccines and therapies for COVID-19 to increase their market share
• In October 2020, Thermo Fisher Scientific announced a USD 700 million investment in CAPEX to cater to COVID-related demand in the biopharma market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-downstream-processing-market

Downstream Processing Market Segmentation

Grand View Research has segmented the global downstream processing market on the basis of product, technology, application, and region:

Downstream Processing Product Outlook (Revenue, USD Million, 2017 - 2028)

• Chromatography Systems
• Filters
• Evaporators
• Centrifuges
• Dryers
• Others

Downstream Processing Technique Outlook (Revenue, USD Million, 2017 - 2028)

• Cell Disruption
• Solid-liquid separation
  • Filtration
  • Centrifugation
• Concentration
  • Evaporation
  • Membrane filtration
• Purification by Chromatography
• Formulation

Downstream Processing Application Outlook (Revenue, USD Million, 2017 - 2028)

• Antibiotic Production
• Hormone Production
• Antibodies Production
• Enzyme Production
• Vaccine Production

Downstream Processing Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa
  • UAE

List of Key Players of Downstream Processing Market

• GE Healthcare
• Merck KGaA
• Sartorius Stedim Biotech S.A.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Repligen
• 3M Company
• Eppendorf AG
• Boehringer Ingelheim International GmbH
• Corning Corporation
• Lonza Group Ltd
• Dover Corporation
• Ferner PLC
• Ashai Kasei

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Clinical Oncology Next Generation Sequencing Market Growth in the Coming Years

 

Clinical Oncology NGS Market Growth & Trends

The global clinical oncology next generation sequencing market size is expected to reach USD 892.61 million by 2028 registering a CAGR of 14.70%, according to a new report by Grand View Research, Inc. Technological advancements in next-generation sequencing coupled with high adoption of companion diagnostics and personalized medicine drive the global market growth. 

In addition, a rise in the utility of next generation sequencing (NGS) for liquid biopsy is expected to increase revenue generation in the market. NGS is employed to sequence circulating tumor DNA (ctDNA) for the analysis of liquid biopsy samples. This leads to efficient molecular profiling of tumors, which, in turn, facilitates real-time, non-invasive monitoring of tumors.

Moreover, a rise in market competitiveness, growth in oncology diagnostics spending, and increasing research activities to develop solutions that can potentially be used for clinical oncology drive market progression. For instance, in January 2021, Spectrum Solutions, LLC collaborated with the UCLA School of Dentistry on saliva-based NGS liquid biopsy research, which would be used for early diagnosis of Non-Small Cell Lung Cancer (NSCLC).

North America dominated the global market in 2020 owing to multiple initiatives taken by various government bodies in the region to screen and prevent cancer, such as Cancer Prevention and Control Research Network, a flagship program by the CDC. Asia Pacific is projected to be the fastest-growing regional market over the forecast period owing to continuous reforms in the pharmaceutical and life sciences industries in the region.

Key players in this market have undertaken strategic alliances to strengthen their market position. For example, in March 2020, Thermo Fisher Scientific signed an agreement with Janssen Biotech, Inc. for the development of CDx for tumor management. Under the agreement, Janssen Research & Development, LLC would validate multiple biomarkers to be used with Thermo Fisher's Oncomine Dx target test for identification of patients with NSCLC

Request a free sample copy or view report summary: Clinical Oncology NGS Market Report

Clinical Oncology NGS Market Report Highlights

• Targeted sequencing & resequencing accounted for the largest market share in 2020 owing to the high adoption of targeted gene panels for oncology diagnostics
• Moreover, the discovery of novel cancer biomarkers further boosts the development of targeted sequencing oncology panels
• Whole-Genome Sequencing (WGS) is projected to register the fastest growth rate from 2021 to 2028 as the technology offers a complete genomic survey of the tumor genome
• This helps in the generation of a detailed map of indels, copy number changes, Single Nucleotide Variations (SNV), and complex structural rearrangements with a single assay
• Companion diagnostics is projected to be the fastest-growing application segment from 2021 to 2028 owing to the high adoption and benefits offered by the technology
• Therefore, major market participants focus on innovative R&D in companion diagnostics to gain approval for novel tests
• For instance, in August 2020, the FDA approved Guardant360 CDx assay; an NGS-based liquid biopsy CDx to identify Epidermal Growth Factor Receptor (EGFR) gene mutations in metastatic NSCLC

Access Press Release@ https://www.grandviewresearch.com/press-release/global-clinical-oncology-next-generation-sequencing-ngs-market

Clinical Oncology NGS Market Segmentation

Grand View Research has segmented the global clinical oncology next generation sequencing market on the basis of technology, workflow, application, end-use, and region:

Clinical Oncology NGS Technology Outlook (Revenue, USD Million, 2017 - 2028)

• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Sequencing & Resequencing Centrifuges

Clinical Oncology NGS Workflow Outlook (Revenue, USD Million, 2017 - 2028)

• Pre-Sequencing
• Sequencing
• Data Analysis

Clinical Oncology NGS Application Outlook (Revenue, USD Million, 2017 - 2028)

• Screening
  • Sporadic Cancer
  • Inherited Cancer
• Companion Diagnostics
• Other Diagnostics

Clinical Oncology NGS End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Hospitals
• Clinics
• Laboratories

Clinical Oncology NGS Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of Clinical Oncology NGS Market

• Illumina, Inc.
• Thermo Fisher Scientific
• Hoffmann-La Roche Ltd.
• Agilent Technologies
• Myriad Genetics
• Beijing Genomics Institute (BGI)
• Perkin Elmer
• Foundation Medicine
• Pacific Bioscience
• Oxford Nanopore Technologies Ltd.
• Paradigm Diagnostics
• Caris Life Sciences
• Partek, Inc.
• Eurofins Scientific S.E.
• Qiagen N.V.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Hospital Gowns Market is Estimated To Attain $8.26 Billion by 2028

 Hospital Gowns Market Growth & Trends

The global hospital gowns market size is expected to reach USD 8.26 billion by 2028 registering a CAGR of 12.8%, according to a new report by Grand View Research, Inc. The rising incidence of Hospital Acquired Infections (HAIs) and increasing number of surgical procedures are the key driving factors for the market growth. The recent outbreak of Covid-19 is also anticipated to have a significant impact on market growth.

The global pandemic has drastically increased the demand for medicines, emergency supplies, and hospital equipment including gowns, antiseptics, and disinfectant products. Covid-19 is a zoonotic virus and bats were considered to be the key reservoir of the virus. The intermediate host has not been identified yet and transmission has mainly taken place through fomites & droplets during close unprotected contact between infector & infected. Till now airborne transmission of the virus has not been reported. Thus, increasing hospital admissions across the globe have increased the demand for hospital gowns.

The WHO has appealed to industries and governments to increase the manufacturing of Personal Protective Equipment (PPE), including hospital gowns, gloves, medical masks, face shields, aprons, respirators, and goggles, by 40% to meet the increasing global demand. It also reported that the rise in demand for these accessories has increased their prices to a major extent. For instance, the price of surgical masks has increased six-fold and the price of hospital gowns has increased two-fold.

Request a free sample copy or view report summary: Hospital Gowns Market Report

Hospital Gowns Market Report Highlights

• In terms of revenue, the surgical gowns segment held the largest share in 2020 owing to the rising incidents of chronic diseases and increasing number of surgical procedures
• The reusable gowns segment is anticipated to witness the fastest growth over the forecast period owing to the increasing cases of Covid-19
• The high-risk hospital gowns segment held the largest share in 2020 owing to the increased demand across the globe
• Asia Pacific is expected to be the fastest-growing regional market over the forecast period owing to the increasing cases of diabetic foot ulcers and rising number of surgical procedures

Access Press Release@ https://www.grandviewresearch.com/press-release/global-hospital-gowns-market

Hospital Gowns Market Segmentation

Grand View Research has segmented the global hospital gowns market on the basis of type, usability, risk type, and region:

Hospital Gowns Type Outlook (Revenue, USD Million, 2016 - 2028)

• Surgical
• Non-surgical
• Patient

Hospital Gowns Usability Outlook (Revenue, USD Million, 2016 - 2028)

• Disposable Gowns
  • Low
  • Average
  • Premium
• Reusable Gowns
  • Low
  • Average
  • Premium

Hospital Gowns Risk Type Outlook (Revenue, USD Million, 2016 - 2028)

• Minimal
• Low
• Moderate
• High

Hospital Gowns Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Hospital Gowns Market

• Medline Industries, Inc.
• Standard Textile Co., Inc.
• Angelica
• AmeriPride Services, Inc.
• 3M
• Cardinal Health

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biopharmaceutical Excipients Market Projected to Register 6.5% CAGR from 2021 to 2028: Grand View Research Inc.

 

Biopharmaceutical Excipients Market Growth & Trends

The global biopharmaceutical excipients market size is expected to reach USD 3.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028. The factors driving the market growth include increasing development of biosimilars, instability associated with drugs & vaccines, and growing focus on the development of novel drugs, among others.

The changing regulatory scenarios by both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have impacted drug development. Several legislative proposals are addressing new ways for lowering the cost of prescription drugs. Similarly, in recent years there is an increasing focus on drug-manufacturing quality has led to several recalls by FDA and the EMA. Hence, the stringent investigations related to an examination of drugs are likely to promote the use of specific excipients for developing efficient drugs.

In addition, companies are collaborating with government authorities for increasing the application of novel compounds. For instance, in December 2019, U.S. FDA started a pilot program to evaluate novel biopharmaceutical excipients. Later, the initiative was supported by several companies such as AstraZeneca, Regeneron, and Janssen for FDA’s plan to review novel biopharmaceutical excipients. Regeneron highlighted different novel compounds that can potentially help in improving public health for example hydrophobic salts can reduce the viscosity of highly concentrated antibody formulations.

Moreover, the rising focus on the rapid development of COVID-19 vaccines and therapeutic drugs is further driving the market growth. Excipients have an essential role in the development of biologics as it helps in stabilizing the drug during storage and processing. The use of appropriate biopharmaceutical excipients enables the development of novel therapies and robust pharmaceutical products for fighting against the pandemic.

Large-scale pharmaceutical companies signed a long-term supply agreement with companies for supporting the development of COVID-19 vaccines. For instance, in November 2020, Pfizer Inc. signed a five-year contract with Croda International for lipid-based excipients that will be used for manufacturing Pfizer’s COVID-19 vaccine candidate. Similarly, in May 2020, Moderna signed a supply agreement with CordenPharma for the large-scale production of lipid excipient for the development of mRNA-1273, Moderna's COVID-19 vaccine candidate.

Request a free sample copy or view report summary: Biopharmaceutical Excipients Market Report

Biopharmaceutical Excipients Market Report Highlights

• Carbohydrates accounted for the largest revenue share of 36.2% in 2020 owing to the increasing use of carbohydrates owing to their several advantages
• The advantages include it helps the efficient binding of tablet ingredients, enables accurate dosing and protecting the tablet from harsh environmental conditions, among others
• Sucrose amongst the carbohydrates dominated with a market share of 32.8% owing to its increasing application in stabilizing proteins
• Starch is expected to witness the fastest CAGR of 6.6% from 2021 to 2028 owing to the increasing launch of new starch excipients
• For instance, in May 2019, Colorcon Inc. launched STARTAB, a new starch tableting excipient. It is developed by directly compressible starch for enhancing the stability of moisture sensitive API
• North America has emerged as the highest revenue-generating region, representing a market share of 32.0% in 2020
• Large pharmaceutical companies are entering in collaboration with the companies in the region which can be attributed to market growth
• For instance, in February 2020, MilliporeSigma entered in an agreement with ReForm Biologics LLC for commercializing ReForm’s excipients that are used in biotherapeutic formulations
• In Asia Pacific, the market is expected to witness a lucrative CAGR of 7.0% from 2021 to 2028 owing to the increasing production of biosimilar drugs in the region
• The government in this region is promoting biosimilar development. For instance, the government of South Korea provided regulatory guidance to local biosimilars companies for aiming to develop around 22.0% of global biosimilarsby 2020

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biopharmaceutical-excipients-market

Biopharmaceutical Excipients Market Segmentation

Grand View Research has segmented the global biopharmaceutical excipients market on the basis of product and region:

Biopharmaceutical Excipients Product Outlook (Volume, Tonnes; Revenue, USD Million, 2017 - 2028)

• Solubilizers & Surfactants/Emulsifiers
  • Triglycerides
  • Esters
  • Others
• Polyols
  • Mannitol
  • Sorbitol
  • Others
• Carbohydrates
  • Sucrose
  • Dextrose
  • Starch
  • Others
• Specialty Excipients

Biopharmaceutical Excipients Regional Outlook (Volume, Tonnes; Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • South Korea
  • Philippines
  • New Zealand
  • Australia
  • Singapore
  • Indonesia
• Latin America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players of Biopharmaceutical Excipients Market

• Merck KGaA
• Signet Excipients Pvt. Ltd
• Sigachi Industries Limited
• Associated British Foods plc
• Spectrum Chemical Manufacturing Corp.
• Roquette Frères
• IMCD
• Clariant
• DFE Pharma
• Colorcon
• BASF SE
• Evonik Industries AG
• RETTENMAIER & SÖHNE GmbH + Co KG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.